PTC Operating Cash Flow increased by 19.0% to $320.92M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.1%, from $281.31M to $320.92M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 23.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $88.03M | $45.32M | $137.74M | $142.33M | $116.77M | $38.50M | $180.92M | $210.95M | $169.22M | $49.77M | $187.34M | $250.73M | $213.80M | $98.11M | $238.43M | $281.31M | $243.93M | $104.03M | $269.75M | $320.92M |
| QoQ Change | — | -48.5% | +203.9% | +3.3% | -18.0% | -67.0% | +369.9% | +16.6% | -19.8% | -70.6% | +276.4% | +33.8% | -14.7% | -54.1% | +143.0% | +18.0% | -13.3% | -57.4% | +159.3% | +19.0% |
| YoY Change | — | — | — | — | +32.6% | -15.1% | +31.4% | +48.2% | +44.9% | +29.3% | +3.5% | +18.9% | +26.3% | +97.1% | +27.3% | +12.2% | +14.1% | +6.0% | +13.1% | +14.1% |